Post by The Roger Williams Institute of Liver Studies

Having reflected on 60 years of liver medicine, Day 2 at #KingsLiver60th is all about the future. This afternoon's sessions focus on global challenges in modern hepatology, and the major research platforms bridging discovery and clinical care – from organoids and regenerative medicine to microbiome science, faecal transplantation, and personalised therapies for conditions such as MASH. Ipsen Madrigal Pharmaceuticals Gilead Sciences King's College Hospital NHS Foundation Trust King's College London King's Health Partners